Viral infection causes rapid sensitization to lipopolysaccharide: central role of IFN-alpha beta

Research output: Contribution to journalJournal articleResearchpeer-review

LPS is the major active agent in the pathogenesis of Gram-negative septic shock. In this report we have studied the influence of concurrent viral infection on the outcome of LPS-induced shock. We find that infection with vesicular stomatitis virus sensitizes mice to LPS at an early time point following infection. Treatment of mice with the chemical IFN inducer, polyinosinic:polycytidylic acid, has a similar effect. This hypersensitivity to LPS correlated with hyperproduction of TNF-alpha in vivo. The cellular and molecular mechanisms underlying this phenomenon were investigated using Ab-depleted and gene-targeted mice. Our results revealed that while NK cell depletion and elimination of IFN-gamma partially protected against the sensitizing effects of vesicular stomatitis virus and polyinosinic:polycytidylic acid, the most striking effect was observed in IFN-alphabetaR-deficient mice. Thus hyperproduction of TNF-alpha was completely abrogated in IFN-alphabetaR-deficient mice, indicating that the principal mechanism underlying rapid virus-induced sensitization to LPS is an IFN-alphabeta-mediated priming of mice for an augmented production of TNF-alpha in response to LPS. This conclusion was further supported by the finding that pretreatment of mice with rIFN-alphabeta mimicked the effect of viral infection. In conclusion, our results reveal a previously unrecognized proinflammatory effect of IFN-alphabeta and point to a new pathway through which viral infection may influence the outcome of concurrent bacterial infection.
Original languageEnglish
JournalJournal of Immunology
Volume166
Issue number2
Pages (from-to)982-8
Number of pages6
ISSN0022-1767
Publication statusPublished - 2001

Bibliographical note

Keywords: Animals; B-Lymphocytes; Disease Susceptibility; Female; Humans; Injections, Intraperitoneal; Interferon Inducers; Interferon Type I; Interferon Type I, Recombinant; Interferon-gamma; Killer Cells, Natural; Lipopolysaccharides; Lymphocytic Choriomeningitis; Lymphocytic choriomeningitis virus; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Nude; Poly I-C; Rhabdoviridae Infections; Shock, Septic; T-Lymphocytes; Time Factors; Tumor Necrosis Factor-alpha; Vesicular stomatitis Indiana virus

ID: 9702695